Valley Wealth Managers’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Valley Wealth Managers's DGX Position: Q4 2022 in Review
Valley Wealth Managers sold out of Quest Diagnostics (DGX) in Q4 2022, closing a stake of 250 shares — an estimated $31K sold.
Valley Wealth Managers first reported a position in DGX in Q1 2019 and held it in 10 quarters. The position peaked at $3.22M in Q1 2021. 879 funds tracked by Wall St. Rank hold DGX as of Q4 2022.
- Valley Wealth Managers reported no remaining Quest Diagnostics position as of Q4 2022 after selling out during the quarter.
- Valley Wealth Managers sold 250 Quest Diagnostics shares in Q4 2022, an estimated $31K.
- Valley Wealth Managers first reported a position in Quest Diagnostics in Q1 2019 and held it in 10 quarters.
- Valley Wealth Managers's Quest Diagnostics position peaked at $3.22M in Q1 2021.
- 879 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.
Based on Valley Wealth Managers's 13F filing for Q4 2022, filed 1 Feb 2023.